These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 19567893
1. Moderation of antidepressant response by the serotonin transporter gene. Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A, Mors O, Maier W, Hauser J, Souery D, Placentino A, Zobel A, Larsen ER, Czerski PM, Gupta B, Hoda F, Perroud N, Farmer A, Craig I, Aitchison KJ, McGuffin P. Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893 [Abstract] [Full Text] [Related]
2. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder. Won ES, Chang HS, Lee HY, Ham BJ, Lee MS. Neuropsychobiology; 2012 Jul; 66(4):221-9. PubMed ID: 23095326 [Abstract] [Full Text] [Related]
3. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. Strohmaier J, Wüst S, Uher R, Henigsberg N, Mors O, Hauser J, Souery D, Zobel A, Dernovsek MZ, Streit F, Schmäl C, Kozel D, Placentino A, Farmer A, McGuffin P, Aitchison KJ, Rietschel M. World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237 [Abstract] [Full Text] [Related]
4. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. Keers R, Uher R, Huezo-Diaz P, Smith R, Jaffee S, Rietschel M, Henigsberg N, Kozel D, Mors O, Maier W, Zobel A, Hauser J, Souery D, Placentino A, Larsen ER, Dmitrzak-Weglarz M, Gupta B, Hoda F, Craig I, McGuffin P, Farmer AE, Aitchison KJ. Pharmacogenomics J; 2011 Apr; 11(2):138-45. PubMed ID: 20212518 [Abstract] [Full Text] [Related]
5. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paddock S, McMahon FJ, Manji H, Lipsky RH. Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812 [Abstract] [Full Text] [Related]
6. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ, Kim DK. JAMA; 2006 Oct 04; 296(13):1609-18. PubMed ID: 17018806 [Abstract] [Full Text] [Related]
7. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study. Outhred T, Das P, Dobson-Stone C, Felmingham KL, Bryant RA, Nathan PJ, Malhi GS, Kemp AH. Aust N Z J Psychiatry; 2014 Dec 04; 48(12):1115-25. PubMed ID: 24810870 [Abstract] [Full Text] [Related]
8. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Davis S, Kirshner MA, Houck PR, Stack JA, Reynolds CF, Kupfer DJ. Neuropsychopharmacology; 2000 Nov 04; 23(5):587-90. PubMed ID: 11027924 [Abstract] [Full Text] [Related]
9. Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders. Rotberg B, Kronenberg S, Carmel M, Frisch A, Brent D, Zalsman G, Apter A, Weizman A. J Child Adolesc Psychopharmacol; 2013 Mar 04; 23(2):117-22. PubMed ID: 23510446 [Abstract] [Full Text] [Related]
10. Genetic predictors of response to antidepressants in the GENDEP project. Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, Zobel A, Czerski PM, Larsen ER, Souery D, Giovannini C, Gray JM, Lewis CM, Farmer A, Aitchison KJ, McGuffin P, Craig I. Pharmacogenomics J; 2009 Aug 04; 9(4):225-33. PubMed ID: 19365399 [Abstract] [Full Text] [Related]
11. Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder. Jarčušková D, Tkáč I, Hlaváčová N, Yaluri AS, Kozárová M, Habalová V, Klimčáková L, Židzik J, Javorský M, Bednářová A. BMC Psychiatry; 2024 Oct 15; 24(1):690. PubMed ID: 39407134 [Abstract] [Full Text] [Related]
12. Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial. Lewis G, Mulligan J, Wiles N, Cowen P, Craddock N, Ikeda M, Grozeva D, Mason V, Nutt D, Sharp D, Tallon D, Thomas L, O'Donovan MC, Peters TJ. Br J Psychiatry; 2011 Jun 15; 198(6):464-71. PubMed ID: 21263010 [Abstract] [Full Text] [Related]
13. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial. Perroud N, Uher R, Marusic A, Rietschel M, Mors O, Henigsberg N, Hauser J, Maier W, Souery D, Placentino A, Szczepankiewicz A, Jorgensen L, Strohmaier J, Zobel A, Giovannini C, Elkin A, Gunasinghe C, Gray J, Campbell D, Gupta B, Farmer AE, McGuffin P, Aitchison KJ. BMC Med; 2009 Oct 15; 7():60. PubMed ID: 19832967 [Abstract] [Full Text] [Related]
14. Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults. Lenze EJ, Goate AM, Nowotny P, Dixon D, Shi P, Bies RR, Lotrich FK, Rollman BL, Shear MK, Thompson PA, Andreescu C, Pollock BG. J Clin Psychopharmacol; 2010 Dec 15; 30(6):672-7. PubMed ID: 21105279 [Abstract] [Full Text] [Related]
15. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients. Smits KM, Smits LJ, Peeters FP, Schouten JS, Janssen RG, Smeets HJ, van Os J, Prins MH. Psychiatr Genet; 2008 Aug 15; 18(4):184-90. PubMed ID: 18628680 [Abstract] [Full Text] [Related]
16. The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression. Dreimüller N, Tadić A, Dragicevic A, Boland K, Bondy B, Lieb K, Laux G, Maier W, Müller MJ, Rao ML, Rietschel M, Röschke J, Zill P, Hiemke C. Pharmacopsychiatry; 2012 May 15; 45(3):108-13. PubMed ID: 22086748 [Abstract] [Full Text] [Related]
17. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life. Seripa D, Pilotto A, Paroni G, Fontana A, D'Onofrio G, Gravina C, Urbano M, Cascavilla L, Paris F, Panza F, Padovani A, Pilotto A. J Psychopharmacol; 2015 May 15; 29(5):623-33. PubMed ID: 25827644 [Abstract] [Full Text] [Related]
18. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study. Outhred T, Das P, Dobson-Stone C, Felmingham KL, Bryant RA, Nathan PJ, Malhi GS, Kemp AH. J Affect Disord; 2016 May 15; 196():11-9. PubMed ID: 26896742 [Abstract] [Full Text] [Related]
19. Serotonin transporter gene (5-HTTLPR) polymorphism and efficacy of selective serotonin reuptake inhibitors--do we have sufficient evidence for clinical practice. Karlović D, Karlović D. Acta Clin Croat; 2013 Sep 15; 52(3):353-62. PubMed ID: 24558768 [Abstract] [Full Text] [Related]
20. [Association between polymorphisms of ins/del in the 5-HTT gene and T102C in the 5HTR2A gene and the drug response for escitalopram and nortriptyline in depressed patients]. Rajewska-Rager A, Dmitrzak-Weglarz M, Kapelski P, Skibińska M, Kaczmarkiewicz-Fass M, Hauser J. Psychiatr Pol; 2008 Sep 15; 42(6):903-14. PubMed ID: 19441667 [Abstract] [Full Text] [Related] Page: [Next] [New Search]